Europe Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, Bridge-To-Recovery (BTR) Therapy), Age Group (Adult, Pediatric), Indication (Congestive Heart Failure, Congenital Heart Disease, Myocarditis, Cardiac Arrest, Familial Arrhythmias and Arrhythmic, Cardiomyopathies, Advanced Heart Failure, Others), Generation (Second Generation Devices, Third Generation Devices, First Generation Devices), Durability (Long-Term, Intermediate-Term, Short-Term), Design (Axial, Centrifugal), Pulse Type (Nonpulsatile, Pulsatile), End User (Hospitals, Cardiac Cath Laboratories, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Germany, France, United Kingdom, Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium, Ireland, Rest of Europe) Industry Trends and Forecast to 2029.
· Europe left ventricular assist device (LVAD) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.2% in the forecast period of 2022 to 2029 and is expected to reach USD 540.47 million by 2029. Increasing technological advancements in the left ventricular assist device act as driver for the left ventricular assist device (LVAD) market growth.
· A left ventricular assist device (LVAD) is a mechanical pump implanted in patients with heart failure. It helps the left bottom chamber of the heart (left ventricle) pump blood out of the ventricle to the aorta and the rest of the body.
· It is used for patients who have reached end-stage heart failure. The LVAD is surgically implanted, a battery-operated, mechanical pump, which helps the left ventricle (main pumping chamber of the heart) pump blood to the rest of the body.
Request-a-sample
Left Ventricular Assist Device (LVAD) Market Scope and Market Size
The left ventricular assist device (LVAD) market is segmented on basis of product type, therapy, age group, indication, generation, durability, design, pulse type, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Europe left ventricular assist device (LVAD) market is categorized into ten notable segments such as product type, therapy, age group, indication, generation, durability, design, pulse type, end user, and distribution channel.
On the basis of product type, the Europe left ventricular assist device (LVAD) market is segmented into heart pump, controller, batteries and wires. Batteries are further segmented into rechargeable and non-rechargeable. In 2022, the heart pump is expected to dominate the market as it performs the functions of the heart without replacing it and allows patients to live longer than those who are only treated with medical therapy.
Based on therapy, the Europe left ventricular assist device (LVAD) market is segmented bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-candidacy (BTC) therapy, bridge-to-recovery (BTR) therapy. In 2022, the bridge-to-transplant (BTT) sector is anticipated to dominate the market because it helps patients wait for a transplant and prevents further damage to the heart and other organs until a donor is available.
· Based on age group, the Europe left ventricular assist device (LVAD) market is segmented into adult and pediatric. Adult is further segmented into 19-39 years, 40-59 years, 60-79 years, and above 80 years. In 2022, the adult-segment is expected to dominate the market since the majority of heart failure events occur in adults. The prevalence is 1-2% of the European population, rising to more than 10% among people over the age of 70. This could imply that more than 10 million people suffer from heart failure.
· Based on indication, the Europe left ventricular assist device (LVAD) market is segmented into congestive heart failure, congenital heart disease, myocarditis, cardiac arrest, familial arrhythymias and arrhythmic cardiomyopathies, advanced heart failure and others. In 2022, congestive heart failure is expected to dominate the market since it is the most common diagnosis in hospitalized patients over age 65. In Europe, more than 16 million people have been diagnosed with CHF.
· Based on generation, the Europe left ventricular assist device (LVAD) market is segmented into second generation devices, third generation devices, and first generation devices. In 2022, the market is dominated by second-generation rotary pumps, which have the advantage of a smaller design and the potential for greater long-term mechanical reliability by eliminating the reservoir chamber and valves required.
· Based on durability, the Europe left ventricular assist device (LVAD) market is segmented into long-term, intermediate-term, short-term. In 2022, the long-term segment is expected to dominate to lead the market due to the need to keep supporting the heart pumps for longer duration, which is boosting market growth.
· Based on design, the Europe left ventricular assist device (LVAD) market is segmented into axial and centrifugal. In 2022, axial segment is expected to dominate since it performs efficiently at high rotating speeds and its decreased preload.
· Based on pulse type, the Europe left ventricular assist device (LVAD) market is segmented into nonpulsatile and pulsatile. In 2022, nonpulsatile category segment is expected to dominate the market because LVADs are being used more frequently in destination therapy, any adverse effects of inadequate arterial pulsatility on peripheral structures might be greatly magnified with the long implantation periods associated with this type of therapy.
· Based on end user, the Europe left ventricular assist device (LVAD) market is segmented into hospitals, specialty clinics, cardiac cath laboratories and others. In 2022, the hospitals sector segment is expected to dominate due to a growing pool of cardiovascular patients as a result of changing lifestyles and an aging population. In 2020, there were over 19,000 hospitals in 23 European countries.
· Based on distribution channel, the Europe left ventricular assist device (LVAD) market is segmented into direct tender, retail sales and others. In 2022, the direct tender sector is expected to dominate because it provides accountability and higher quality products due to the competition, which increases demand for these items.
Left Ventricular Assist Device (LVAD) Market Country Level Analysis
· The countries covered in the Europe left ventricular assist device (LVAD) market report are the Germany, France, United Kingdom, Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium, Ireland, Rest of Europe.
Competitive Landscape and Left Ventricular Assist Device (LVAD) Market Share Analysis
· Left ventricular assist device (LVAD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to left ventricular assist device (LVAD) market.
The major companies which are dealing in the left ventricular assist device (LVAD) are
· ABIOMED,
· Abbott, Evaheart, Inc,
· Saft,
· Berlin Heart,
· CorWave SA,
· Jarvik Heart, Inc.
Full Access of Report @
https://www.databridgemarketresearch.com/reports/europe-left-ventricular-assist-device-lvad-market
MAJOR TOC OF THE REPORT
· INTRODUCTION
· MARKET SEGMENTATION
· EXECUTIVE SUMMARY
· PREMIUM INSIGHTS
· MARKET OVERVIEW
· QUESTIONNAIRE
Get TOC Details
https://www.databridgemarketresearch.com/toc/?dbmr=europe-left-ventricular-assist-device-lvad-market
Related Reports:
· Middle East and Africa Cheese Based Snacks Market Destine to Reach Size, Share, Industry Growth Rate, Technological Advancements, Demand & Revenue Outlook https://www.databridgemarketresearch.com/reports/middle-east-and-africa-cheese-based-snacks-market
· North America Cheese Based Snacks Market to Garner Size, Share, Growth, Demand, Challenges, Opportunities and Competitive outlook https://www.databridgemarketresearch.com/reports/north-america-cheese-based-snacks-market
· Bakery Inclusions Market Is Likely to Upsurge, Size, Share, Trend, Demand, Challenges and Competitors Outlook https://www.databridgemarketresearch.com/reports/global-bakery-inclusions-market
· Stroke Diagnostics Market to Exhibit a Striking Growth of Size, Share, Trends, Competitive Scenario and Industry Growth Analysis https://www.databridgemarketresearch.com/reports/global-stroke-diagnostics-market
· Europe Stroke Diagnostics Market to Perceive Remarkable, Size, Share, Trends, Demand, Opportunities and Segmentation Analysis https://www.databridgemarketresearch.com/reports/europe-stroke-diagnostics-market
· Asia-Pacific Stroke Diagnostics Market is expected to reach the Value of, Size, Share, Growth, Demand and Opportunity Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-stroke-diagnostics-market
· Middle East and Africa Stroke Diagnostics Market Is Predictable to Touch Size, Share, Business Opportunities, Demand, Upcoming Trends, Segmentation and Revenue Outlook https://www.databridgemarketresearch.com/reports/middle-east-and-africa-stroke-diagnostics-market
· North America Stroke Diagnostics Market to Perceive Notable Growth of Size, Share, Trends, Demand and Segmentation Analysis https://www.databridgemarketresearch.com/reports/north-america-stroke-diagnostics-market
· Rice Protein Based Infant Formula Market to Garner, Growth Insight, Share, Competitive Analysis, Statistics, and Trends forecast https://www.databridgemarketresearch.com/reports/global-rice-protein-based-infant-formula-market
· Europe Rice Protein Based Infant Formula Market to Exhibit a Striking Growth of, Future Developments, Opportunities, Trends, Revenue Growth and Demand Outlook https://www.databridgemarketresearch.com/reports/europe-rice-protein-based-infant-formula-market
· North America Rice Protein Based Infant Formula Market to Experience Substantial Growth of Size, Share, Rising Demand and Competitors Outlook https://www.databridgemarketresearch.com/reports/north-america-rice-protein-based-infant-formula-market
· Asia-Pacific Rice Protein Based Infant Formula Market Is Likely to Upsurge, Growth Tactics, Future Strategies, Size, Share and competitive Outlook https://www.databridgemarketresearch.com/reports/asia-pacific-rice-protein-based-infant-formula-market
· Middle East and Africa Rice Protein Based Infant Formula Market Destine to Reach, Size, Share, Industry Growth Rate, Demand, Trends & Revenue Forecast https://www.databridgemarketresearch.com/reports/middle-east-and-africa-rice-protein-based-infant-formula-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian